Clinical trial
Perioperative Platelet Inhibition With Acetylsalicylic Acid Targeting Intraoperative Tumor Cell Seeding in Patients With Resectable Tumors of the Pancreatic Head - a Randomized, Controlled Multicenter Study
NCT05637567 is registered in ClinicalTrials.gov with German Cancer Research Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Perioperative Platelet Inhibition With Acetylsalicylic Acid Targeting Intraoperative Tumor Cell Seeding in Patients With Resectable Tumors of the Pancreatic Head - a Randomized, Controlled Multicenter Study
- Lead sponsor
- German Cancer Research Center
- Phase
- Phase 2
- Overall status
- Not yet recruiting
- Start date
- April 30, 2024
- Completion date
- March 31, 2029
- Enrollment
- 170 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
pancreatic cancer resectable